EcoDrugPlus

Endothelial Pas Domain Protein 1

Ensembl ID : ENSLOCG00000016337
Gene Symbol: EPAS1
3 Cross references
221 Possible Orthologues:

Endothelin B Receptor-Like

Ensembl ID : ENSLOCG00000005403
Gene Symbol: LOC102695491
3 Cross references
197 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSLOCG00000003479
Gene Symbol: ECE1
3 Cross references
229 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSLOCG00000008801
Gene Symbol: EDNRA
3 Cross references
265 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSLOCG00000013329
Gene Symbol: EZH2
3 Cross references
238 Possible Orthologues:

Eph Receptor B4b

Ensembl ID : ENSLOCG00000013666
Gene Symbol: EPHB4B
1 Cross references
169 Possible Orthologues:

Epidermal Growth Factor Receptor A (Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog, Avian)

Ensembl ID : ENSLOCG00000011537
Gene Symbol: EGFRA
1 Cross references
287 Possible Orthologues:

Epoxide Hydrolase 2, Cytoplasmic

Ensembl ID : ENSLOCG00000016711
Gene Symbol: EPHX2
1 Cross references
203 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSLOCG00000012694
Gene Symbol: ERBB2
3 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3b

Ensembl ID : ENSLOCG00000003677
Gene Symbol: ERBB3B
1 Cross references
281 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4a

Ensembl ID : ENSLOCG00000004529
Gene Symbol: ERBB4A
1 Cross references
237 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSLOCG00000016285
Gene Symbol: ESR1
3 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).